Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.

Onco Targets Ther · 2025 · PMC12206598 · PMID 40589862

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendp = 0.052so close (0.05 < p ≤ 0.1)

The univariate analysis showed a trend that patients without post-resection radiotherapy experienced longer OS than patients with post-resection radiotherapy [HR 0.48 (95% CI 0.23 to 1.01, p = 0.052)], which was not confirmed by multivariate analysis, with an adjusted HR of 0.90 (95% CI 0.37 to 2.20, p = 0.816).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.